Inclusion Criteria:  Subjects consenting to undergoing phacoemulsification and IOL implant surgery for the treatment of symptomatic age-related lens cataract, and then electing to undergo the study, Subjects must be willing and able to return for scheduled treatment and follow-up examinations at 1 and 3 months.  Exclusion Criteria:  Pre-existing corneal endothelium pathology Presence of guttae Narrow angle glaucoma or advanced glaucoma Psuedoexfoliation Zonular abnormalities Corneal endothelial cell density less than 1800 cells/mm2 Uveitis Anterior chamber depth less than 2.5mm or greater than 3.75mm Cataract grade LOCS II > 3 Posterior polar cataract Planned implantation of IOL > 25D Prior ocular surgery in the study eye History of medications with potential corneal endothelial cell toxicity Any condition that in the surgeon's judgement should exclude the subject from study enrollment. Current participation in another drug or device clinical study, or participation in such a clinical study within the prior six months and during the duration of the current study